Sacubitril/valsartan improves functional class and objective parameters in heart failure patients with reduced ejection fraction and its discontinuation is associated with a poor prognosis.
28 May 2018 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
12th of October University Hospital, Madrid (Spain)
38 More presentations in this session
Access the full session
The Event
Heart Failure 2018
28 May 2018
08:30 CET
You may be interested in
Congress Presentation
